Clinical Study

Transarterial Chemoembolization of Metastatic Colorectal Carcinoma with Drug-Eluting Beads, Irinotecan (DEBIRI): Multi-Institutional Registry

Table 1

Clinical demographic data in 30 colorectal metastasis patients treated with LC Bead.

Demographic (%)

Caucasian24 (80%)
African American5 (19%)
Asian1 (1%)

Age, median (range)55 (40–75)

Gender
Male19 (63%)
Female11 (47%)

Prior chemotherapy
FOLFOX25
FOLFIRI11
Avastin27
Xeloda7
Erbitux3
5FU4
Vectibex2

Adverse Events in 57 total bead treatments
Cholecystititis1 (2%) Grade 3
Dehydration1 (2%) Grade 2
Gastritis1 (2%) Grade 1
Hypertension3 (5%) Grades 1–2
Infection1 (2%) Grade 1
Liver dysfunction/failure2 (4%) Grades 3,5
Nausea5 (9%) Grades 1–2
Pain1 (2%) Grade 1
Vomiting3 (5%) Grades 1–2